Destin Plastic Surgery Serving Panama City & Pensacola, FL


Destin, Florida (July 29, 2009) – In the makeup industry, even though sales have been declining in this recession, the eyes still have it. Mascara has been the one bright spot in the U.S. cosmetics industry within the past six months — while makeup industry sales fell 4% from year-earlier levels to $251 million, sales of mascara rose 4% to $22 million, according to market research firm NPD Group.

Mascara is the makeup product that most women say they use, NPD says. About 83% of American women say they use mascara — that figure is much higher than say, lipstick, which only 64% of women say they use, NPD says. It’s also the most frequently used item by women, according to NPD global beauty industry analyst Karen Grant, which reports that 51% of women say they use mascara at least once a day.

And if longer, thicker, darker eyelashes are that in demand, then Allergan’s new prescription eyelash growth enhancer will be a huge success. LATISSE™ is the first and only treatment approved by the FDA to Increases Length, Thickness and Darkness of Eyelashes.

Available at Destin Plastic Surgery, LATISSE™ is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE™ users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE™ is required. If use of LATISSE™ is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

“I have observed two of our patients using LATISSE™”, said Dr. William Burden, Destin Plastic Surgery. “After 12 weeks of use, I observed statistically significant differences in eyelash length and thickness. Others have asked these ladies how they got those eyelashes!”

“Now that LATISSE™ is available at our office, I am excited by the amount of satisfaction it will bring to our patients,” said Dr. Scott Ennis of Destin Plastic Surgery. “The price point is very moderate considering what ladies spend on mascara and other eye make up.”

Allergan launched Latisse nationwide in the first quarter of 2009. Recently, their new campaign featuring spokewomen Brooke Shields, has been all over the media.

Allergan estimates global peak sales of LATISSE™ could exceed $500 million per year surpassing BOTOX® Cosmetic, another Allergan product, that has been the #1 non-surgical procedure 7 years in a row. Additionally, they expect LATISSE™ to have 3 times the patient base of the 5 million average BOTOX® Cosmetic patients.

Actual LATISSE™ Patient of Destin Plastic Surgery after 12 weeks of use. Patients are available for interviews.


Dr. William R Burden, MD, FACS and Dr. L. Scott Ennis, MD, FACS of Destin Plastic Surgery are known for their experience and dedication to staying in the forefront of leading technology in plastic surgery. They perform over a thousand procedures per year, and are recognized for their endoscopic and minimal incision surgery including the “No Scar on the Breast” and “No Scar on the Face” techniques. Drs Burden and Ennis have the distinction of being dual board certified in Plastic and Reconstructive Surgery as well as General Surgery. They treat many patients from the southeast including Panama City, Pensacola, Tallahassee, Dothan, Atlanta, and Birmingham with referrals coming from all regions of the United States and abroad. Many people travel from Europe, South America and Asia to Destin Plastic Surgery to seek out their services.

Destin Plastic Surgery and its affiliated Anti-Aging Skincare Clinic also specialize in the most popular, non surgical procedures and medical skincare products. Destin Plastic Surgery is designated as a double diamond provider of BOTOX® Cosmetic and JUVÉDERM™ and has been distinguished as one of the largest providers of Restylane Injectable gel in the country. For more information, please visit our website or call (850) 654-1194.


Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential – to see more clearly, move more freely, express themselves more fully. The Company employs more than 7,500 people worldwide and operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.

SOURCE: Allergan, Inc.

Leave a Reply

Fields marked with * are required.